Refresh

Mankind Pharma Ltd. - Research Center

543904 MANKIND Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

9,264.81 8,127.15 7,257.04 5,529.60 4,794.41
Expenses

Material consumed

2,961.79 2,888.57 2,477.79 1,821.61 1,612.86

Manufacturing expenses

70.43 62.00 59.73 47.16 46.49

Personnel expenses

1,982.10 1,701.38 1,443.83 1,106.14 991.47

Selling expenses

563.71 385.85 441.38 387.87 208.09

Adminstrative expenses

1,361.68 1,391.97 1,034.69 788.54 692.05

Expenses capitalised

- - - - -

Cost of sales

6,939.70 6,429.77 5,457.42 4,151.31 3,550.96

Operating profit

2,325.10 1,697.38 1,799.61 1,378.29 1,243.46

Other recurring income

266.64 162.78 162.73 148.08 93.85

Adjusted PBDIT

2,591.74 1,860.16 1,962.34 1,526.37 1,337.31

Financial expenses

14.57 27.75 43.83 7.98 10.62

Depreciation

317.61 269.58 120.98 78.19 61.77

Other write offs

- - - - -

Adjusted PBT

2,259.57 1,562.84 1,797.54 1,440.21 1,264.92

Tax charges

436.16 314.58 462.41 355.83 306.70

Adjusted PAT

1,823.41 1,248.26 1,335.13 1,084.37 958.23

Non recurring items

-6.70 -4.86 -0.63 -1.56 -7.33

Other non cash adjustments

- - - - -

Reported net profit

1,816.71 1,243.40 1,334.50 1,082.82 950.90

Earnigs before appropriation

9,685.02 7,868.30 6,164.45 4,829.95 4,111.40

Equity dividend

- - - - 240.62

Preference dividend

- - - - -

Dividend tax

- - - - 61.82

Retained earnings

9,685.02 7,868.30 6,164.45 4,829.95 3,808.95
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com